home
Nottingham University Hospitals Research & Innovation Extranet: Latest news

Third round open for HIEC bids East Midlands worth circa £150K: deadline for expressions of interest 30th May

The 3rd round of HIEC projects in the East Midlands Region is launched. Following the success of previous projects and collaborations, EM HIEC is offering the opportunity to bid for funding to speed the diffusion and adoption of innovation and evidence-based good practice through education and training.

TANDEM trial update: NUH responds to BMJ editorial on use of Avastin for treatment of macular degeneration

To tackle uncertainty about dosing schedule for bevacizumab (Avastin), we are conducting a multicentre randomised trial in England. This study, the TANDEM trial, is a factorial trial comparing low dose with standard dose bevacizumab, and monthly with two monthly review schedules. This issue is of such importance to the NHS, that the unusual step has been taken for a consortium of PCT commissioners in the East Midlands (the East Midlands Specialised Commissioning Group) to commission this trial.